6/4/2025Biocytogen and CTTQ Receive IND Approval in China for Next-Gen Anti-IG...

6/4/2025China Approves First Homegrown 9-Valent HPV Vaccine

6/4/2025Sagimet and Ascletis Report Positive Phase 3 Results for Denifanstat i...

6/4/2025China's Child Health Improves: NHC Official

6/3/2025BioAge Partners with JiKang Thera for APJ Agonist After Obesity Drug S...

6/3/2025Akeso Stumbles as FDA Sets Higher Bar for Ivonescimab Approval

6/3/2025Leads Biolabs' LBL-024 Shows Promising Results in EP-NEC Treatment

6/3/2025Remegen, Junshi Report Strong DV Combo Data in HER2+ Gastric Cancer

6/3/2025CTTQ Achieves Breakthrough in Lung Cancer Treatment

6/3/2025Transcenta's Triple Therapy Shows Promising Results for G/GEJ

6/3/2025Innovent's IBI343 Shows Promise in Advanced Pancreatic Cancer

6/3/2025LongBio Secures Over CNY 200M in Series C Financing

6/3/2025Neowise Licenses TCR Candidate to BeiGene for Off-the-Shelf Cell Thera...

6/3/2025Hanx Biopharma Files for Hong Kong IPO to Advance Innovative Cancer Th...

6/2/2025Mabwell's Mailisheng Injection Gains Chinese Approval for Chemotherapy...

6/2/2025BioNTech's China-Origin Immunotherapy at Center of $11.1B Deal with BM...

6/2/2025Regeneron Licenses Hansoh's Dual GLP-1/GIP Receptor Agonist to Bolster...

6/2/2025OnCusp Unveils Promising Initial Results from First-in-Human Trial of ...

6/2/2025VelaVigo Expands Global Footprint with Strategic U.S. Biotech Collabor...

6/2/2025ArkBio's AK3280 Shows Significant Phase II Efficacy in IPF

6/2/2025BeiGene Redomiciles to Switzerland and Transitions to BeOne Medicines

5/31/2025Recent Official and Executive Moves

5/31/2025China Approves First Homegrown Nine-Valent HPV Vaccine

5/31/2025Cancer Vaccine Trials in China and the U.S. (2014–2024): A Decade of ...

5/31/2025China's Breakthru Weight-Loss Drug Makes Landmark Debut in NEJM

5/31/2025Hengrui Medicine Gains NMPA Approval for Three New Cancer Therapies

5/31/2025Hansoh Receives NMPA Approval for Clinical Trials of Three Innovative ...

5/31/2025China Grants Conditional Approval to Zymeworks' Zanidatamab for HER2-P...

5/31/2025NMPA Issues New Regulations on Experimental Research of Narcotic and P...

5/31/2025NMPA Reopens Comment on Draft Announcement for Strengthening Oversight...

Page:1/51 Total number of articles:1501: [First][<<] [1] [2] [3] [4] [5] [>>] [End]